Vir Biotechnology, Inc. (VIR)
11.70
+0.58
(+5.22%)
USD |
NASDAQ |
Oct 09, 16:00
11.70
0.00 (0.00%)
After-Hours: 20:00
Vir Biotechnology Price to Book Value : 2.015 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 2.015 |
| October 08, 2026 | 1.915 |
| October 07, 2026 | 1.984 |
| October 06, 2026 | 1.998 |
| October 05, 2026 | 2.028 |
| October 02, 2026 | 1.924 |
| October 01, 2026 | 1.944 |
| September 30, 2026 | 1.925 |
| September 29, 2026 | 1.834 |
| September 28, 2026 | 1.810 |
| September 25, 2026 | 1.836 |
| September 24, 2026 | 1.846 |
| September 23, 2026 | 1.910 |
| September 22, 2026 | 1.980 |
| September 21, 2026 | 1.874 |
| September 18, 2026 | 1.825 |
| September 17, 2026 | 1.880 |
| September 16, 2026 | 1.812 |
| September 15, 2026 | 1.798 |
| September 14, 2026 | 1.854 |
| September 11, 2026 | 1.829 |
| September 10, 2026 | 1.822 |
| September 09, 2026 | 1.862 |
| September 08, 2026 | 1.925 |
| September 04, 2026 | 1.960 |
| Date | Value |
|---|---|
| September 03, 2026 | 1.972 |
| September 02, 2026 | 1.980 |
| September 01, 2026 | 2.003 |
| August 31, 2026 | 1.884 |
| August 28, 2026 | 1.865 |
| August 27, 2026 | 1.948 |
| August 26, 2026 | 1.908 |
| August 25, 2026 | 1.844 |
| August 24, 2026 | 1.706 |
| August 21, 2026 | 1.684 |
| August 20, 2026 | 1.586 |
| August 19, 2026 | 1.682 |
| August 18, 2026 | 1.634 |
| August 17, 2026 | 1.617 |
| August 14, 2026 | 1.591 |
| August 13, 2026 | 1.550 |
| August 12, 2026 | 1.543 |
| August 11, 2026 | 1.538 |
| August 10, 2026 | 1.531 |
| August 07, 2026 | 1.519 |
| August 06, 2026 | 1.509 |
| August 05, 2026 | 1.569 |
| August 04, 2026 | 1.579 |
| August 03, 2026 | 1.533 |
| July 31, 2026 | 1.491 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Moderna, Inc. | 13.28 |
| Vaxcyte, Inc. | 3.747 |
| Caribou Biosciences, Inc. | 0.4972 |
| Arrowhead Pharmaceuticals, Inc. | 19.02 |
| Oncolytics Biotech, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 5.734 |
| Price | 11.70 |
| Earnings Yield | -15.91% |
| Market Cap | 1.979B |